Bentley InnoMed GmbH announced the launch of the BeGraft stent graft system, an on-label bridging device for fenestrated ...
Artivion, Inc. announced the presentation of clinical data from the PERSEVERE United States investigational device exemption (I ...
Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced data from the AMDS PERSEVERE clinical trial (the "IDE") was presented in a Late-Breaking ...